Craig Beavers and Kyle Fischer, PharmD, BCCP, MBA, discuss key late-breaking cardiovascular trials expected at the American Heart Association’s upcoming annual meeting, exploring their clinical relevance and implications for pharmacists.
Kyle Fischer, PharmD, BCCP, MBA
Advertisement
Articles by Kyle Fischer, PharmD, BCCP, MBA
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Pharmacy Times
1
FDA Announces Recall 580,000 Bottles of Prazosin Over Potential Carcinogenic Impurity
2
Regular Melatonin Supplementation May Hide Hidden Heart Complications
3
From Type 1 to Type 2 and Beyond: Navigating the Landscape of Diabetes
4
What Health Care Professionals Should Know About Early Type 1 Diabetes Screening
5
